At the time, his wife had found success with Saxenda, a drug whose active ingredient, liraglutide, is FDA-approved for chronic weight management
Bret: Yeah, and, do you think the burden of proof, though, is different from a medication that needs FDA-approval and is expensive and whatnot, and you need a physician to give it to you versus just changing how you eat
Despite these harsh conditions, cell viability and functional integrity can be prevered over extended periods under controlled conditions []
Many patients taking semaglutide experience weight loss of 1015% within 6 months, which typically reduces blood pressure overall
Weight-related examples include exploring the potential for GLP-1s: Reduce the risk of cardiovascular events in adults with obesity and cardiovascular disease (CVD) Reduce complications from heart failure, sleep apnea, peripheral artery disease, and non-alcoholic steatohepatitis (NASH) in patients with obesity Researchers are also evaluating the effects of GLP-1s on diabetic retinopathy and even Alzheimers disease